Alpha-adrenoreceptors in hypertension.

Area of Science:

• Cardiovascular Physiology
• Autonomic Nervous System Research
• Hypertension Pathophysiology

Background:

• Arterial blood pressure is regulated by central autonomic pathways, including the baroreceptor reflex and hypothalamic descending pathways.
• Key neurotransmitters involved are L-glutamate, substance P, norepinephrine (NE), gamma-aminobutyric acid, epinephrine, neuropeptide Y, and acetylcholine.
• Peripheral autonomic neurovascular junctions feature pre- and postjunctional receptors influencing NE release and vascular tone.

Purpose of the Study:

• To elucidate the roles of central neurotransmitters and peripheral autonomic receptors in blood pressure regulation.
• To investigate alterations in alpha- and beta-receptor density in animal models of hypertension.
• To understand the mechanisms by which receptor changes contribute to hypertension pathophysiology.

Main Methods:

• Review of central autonomic pathways and neurotransmitters involved in blood pressure control.
• Analysis of pre- and postjunctional receptor functions at neurovascular junctions.
• Examination of changes in alpha- and beta-receptor density in spontaneously hypertensive rats and experimental renovascular hypertension models.

Main Results:

• Specific neurotransmitters like norepinephrine and acetylcholine play crucial roles in autonomic pathways.
• Peripheral receptors (alpha- and beta-adrenergic, dopaminergic, serotonergic) modulate norepinephrine release and vascular smooth muscle activity.
• Hypertension models exhibit altered receptor densities: increased renal beta- and alpha 2-receptors in spontaneously hypertensive rats, and increased vascular alpha 1- and alpha 2-receptors in renovascular hypertension.
• Beta-receptors are down-regulated in both hypertension models.

Conclusions:

• Changes in autonomic receptor density are implicated in the pathophysiology of hypertension.
• Targeting alpha 1-receptors with antagonists like prazosin can lower blood pressure by blocking vasoconstriction.
• Understanding these receptor dynamics offers potential therapeutic strategies for managing hypertension.